Perrigo (PRGO) Projected to Post Quarterly Earnings on Wednesday

Perrigo (NYSE:PRGO) is projected to release its Q1 2025 earnings data before the market opens on Wednesday, May 7th. Analysts expect the company to announce earnings of $0.53 per share and revenue of $1.09 billion for the quarter.

Perrigo (NYSE:PRGO) last announced its quarterly earnings results on Thursday, February 27th. The company reported $0.93 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.92 by $0.01. The company had revenue of $1.14 billion for the quarter, compared to the consensus estimate of $1.20 billion. Perrigo had a positive return on equity of 7.38% and a negative net margin of 3.64%. On average, analysts expect Perrigo to post $3 EPS for the current fiscal year and $3 EPS for the next fiscal year.

Perrigo Trading Up 1.7 %

NYSE PRGO opened at $25.62 on Wednesday. The stock has a market cap of $3.50 billion, a P/E ratio of -21.90 and a beta of 0.49. Perrigo has a fifty-two week low of $23.14 and a fifty-two week high of $33.46. The stock has a 50 day simple moving average of $26.54 and a two-hundred day simple moving average of $26.07. The company has a debt-to-equity ratio of 0.94, a quick ratio of 1.77 and a current ratio of 2.56.

Perrigo Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 25th. Investors of record on Friday, March 7th were paid a $0.29 dividend. This is a positive change from Perrigo’s previous quarterly dividend of $0.28. The ex-dividend date of this dividend was Friday, March 7th. This represents a $1.16 dividend on an annualized basis and a yield of 4.53%. Perrigo’s dividend payout ratio (DPR) is presently -92.80%.

Wall Street Analysts Forecast Growth

Several research analysts have commented on PRGO shares. Argus lowered shares of Perrigo from a “buy” rating to a “hold” rating in a report on Tuesday, January 14th. Piper Sandler lowered Perrigo from an “overweight” rating to a “neutral” rating and dropped their price target for the company from $34.00 to $27.00 in a research report on Monday, January 6th. Finally, StockNews.com downgraded Perrigo from a “buy” rating to a “hold” rating in a report on Wednesday, February 19th. Four analysts have rated the stock with a hold rating and one has given a buy rating to the company. According to MarketBeat.com, Perrigo has an average rating of “Hold” and an average target price of $33.00.

Insider Buying and Selling at Perrigo

In other Perrigo news, EVP Ronald Craig Janish sold 7,800 shares of Perrigo stock in a transaction dated Monday, March 10th. The shares were sold at an average price of $27.44, for a total value of $214,032.00. Following the completion of the transaction, the executive vice president now directly owns 33,666 shares of the company’s stock, valued at approximately $923,795.04. The trade was a 18.81 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 0.70% of the stock is owned by company insiders.

Perrigo Company Profile

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.